Study: More than a third of Americans take medication that can cause depression

Over one-third of Americans take at least one prescription drug that lists depression as a potential side effect, a new study reports, and users of such drugs have higher rates of depression than those who don’t take such drugs (Source: “Common Drugs May Be Contributing to Depression,” New York Times, June 13, 2018).

According to the study published in the Journal of the American Medical Association, many patients are taking more than one drug that has depression as a side effect, and the study found that the risk of depression increased with each additional such drug taken at the same time.

About 200 prescription drugs can cause depression, and the list includes common medications like proton pump inhibitors (P.P.I.s) used to treat acid reflux, beta-blockers used to treat high blood pressure, birth control pills and emergency contraceptives, anticonvulsants like gabapentin, corticosteroids like prednisone and even prescription-strength ibuprofen. Some of these drugs are also sold over-the-counter in pharmacies.

Dima Mazen Qato, an assistant professor and pharmacist at the University of Illinois at Chicago who was the lead author of the paper, acknowledged that there are still “a lot of unanswered questions,” and that the study only points to a correlation, not a cause-and-effect relationship. 

“We didn’t prove that using these medications could cause someone who was otherwise healthy to develop depression or suicidal symptoms. But we see a worrisome dose-response pattern: The more of these medications that have these adverse effects that you’re taking concurrently, the higher the risk of depression,” Qato said.

Attend HPIO's 2025 Health Policy Summit on Oct. 9, 2025

With limited resources and growing need, investing in policies that deliver the greatest impact is essential. This event will highlight strategies that improve health and wellbeing while reducing healthcare spending. Speakers will provide evidence-informed research responsive to today’s political climate, focusing on what works and why it matters now more than ever.

Register now